NUVB
Nuvation Bio Inc.stockNYSE
Market OpenNov 19, 2026 9:39:04 AM EST
3.91USD+3.439%(+0.13)243,372
Pre-marketNov 19, 2026 9:07:30 AM EST
3.82USD+1.058%(+0.04)
NUVB News
Nuvation Bio reports updated Phase II J201 data for safusidenib ·
Clinical Trials Arena
Nuvation Bio stock hits 52-week low at 3.91 USD ·
Investing.com
Nuvation Bio presents long-term data on brain cancer drug ·
Investing.com
Nuvation Bio stock hits 52-week low at 4.04 USD ·
Investing.com
Nuvation Bio (NUVB) Q3 2026 Earnings Call Transcript ·
The Motley Fool
Nuvation Bio Inc. (NUVB) Q3 2026 Earnings Call Transcript ·
Seeking Alpha
Nuvation Bio to broaden Phase III glioma trial into Europe ·
Clinical Trials Arena